Skip to main content
. Author manuscript; available in PMC: 2006 Sep 1.
Published in final edited form as: Clin Cancer Res. 2005 Sep 1;11(17):6342–6351. doi: 10.1158/1078-0432.CCR-05-0596

Figure 1.

Figure 1

Binding of mesothelin peptides to HLA-A2. Peptides were analyzed for binding to T2 cell line as described in “Materials and Methods.” Peptides were used at concentrations of 0 to 50 μg/ml. P21 peptide (open square), P547 (solid square), positive control (MUC-1 peptide) (+) and negative control (HLA-A3 binding peptide) (X). Results are expressed in mean fluorescence intensity (MFI).